论文部分内容阅读
目的:进一步对卡前列素氨丁三醇在中央性前置胎盘剖宫产中的临床有效性进行分析和探讨。方法:选取于2012年9月至2014年9月期间在我院进行剖宫产的50例中央性前置胎盘孕妇,将其作为本次的研究对象,并分成对照组和观察组,每组各25例,对照组孕妇在分娩后采用缩宫素进行止血,观察组孕妇在分娩后给予卡前列素氨丁三醇,记录产妇术中、术后2小时以及术后24小时出血量,同时观察产妇的不良反应,并进行比较。结果:观察组产妇术中、术后2小时以及术后24小时出血量均少于对照组,两组差异明显(P<0.05),具有统计学意义;在不良反应方面,观察组中有2例患者出现发热,对照组中有1例患者发热,2例患者腹泻,2例患者出现呕吐,两组在不良反应方面没有明显的差异(P>0.05)。结论:针对中央性前置胎盘剖宫产产妇,采用卡前列素氨丁三醇能够有效减少患者术中、术后出血量,降低了患者的生命风险,具有一定的安全性,在临床上具有极为重要的意义,今后值得推广和应用。
Objective: To further investigate the clinical efficacy of carboprost tromethamine in cesarean section of central placenta previa. Methods: Fifty patients with central placenta previa who underwent cesarean section in our hospital from September 2012 to September 2014 were selected as the study subjects and divided into control group and observation group. Each group The control group of pregnant women in the delivery of oxytocin to stop bleeding, the observation group of pregnant women after delivery of carboplatin trometamol, maternal intraoperative and postoperative 2 hours and 24 hours after the operation, the amount of bleeding at the same time Observed maternal adverse reactions, and compared. Results: In the observation group, the amount of hemorrhage during operation was 2 hours after operation and 24 hours after operation were less than those in the control group. There was significant difference between the two groups (P <0.05), with statistical significance. In adverse reactions, there were 2 One patient in the control group experienced fever, one in the control group had fever, two had diarrhea, and two had vomiting. There was no significant difference in adverse reactions between the two groups (P> 0.05). CONCLUSIONS: For cesarean delivery in patients with central placenta previa, the use of carboprost tromethamine can effectively reduce the amount of intraoperative and postoperative bleeding, reduce the patient’s life risk, have a certain safety, and have clinically Extremely important significance, worth promoting and application in the future.